Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
批准号:
8661107
负责人:
Paul Stephen Keim
金额:
$86.81万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-15 至 2015-11-30
关键词:
Acinetobacter baumanniiAntibiotic ResistanceAntibiotic susceptibilityAntibioticsAntimicrobial ResistanceArizonaBioinformaticsBiological AssayBiotechnologyCharacteristicsClinicalClinical MedicineClinical MicrobiologyClinical TrialsCollaborationsCollectionComputer SimulationComputer softwareDataData AnalysesDatabasesDecision MakingDetectionDevelopmentDiagnosticDiseaseEvaluationExhibitsFutureGene ExpressionGene MutationGenesGenetic MaterialsGenomicsGenotypeGoalsHealthHospitalsHumanHuman ResourcesIn SituIn VitroInfectionKlebsiella pneumonia bacteriumKnowledgeLaboratoriesLeadLibrariesMedicalMicrobiological TechniquesMolecularMolecular EpidemiologyMulti-Drug ResistanceOutcomePathogen detectionPatientsPerformancePhenotypeProcessProtocols documentationPseudomonas aeruginosaPublic HealthPublic Health PracticeReadingReportingReproducibilityResearchResearch DesignResearch InstituteResistanceRunningSamplingScienceSensitivity and SpecificityStagingStaphylococcus aureusStreptococcus pneumoniaeSystemTechnologyTestingTrainingTranslatingTranslational ResearchTranslationsUpdateValidationWorkbasebench to bedsideclinical applicationclinically significantcommercializationdensitydesigngenome sequencingimprovedmembernew technologynovelpathogenprogramsrapid detectionrepositoryresearch clinical testingscreeningsuccesstooluser-friendly
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The current era of multi-drug resistance is having dramatic impacts on human health, public health and the practice of clinical medicine. Improved technology is needed to provide prompt and accurate information to treating clinicians for best patient management. The overarching goal on this project is to develop, validate and translate a rapid detection and expression array, for the clinical laboratory setting, to comprehensively characterize antibiotic resistance in important pathogens (Pseudomonas aeruginosa, Klebsiella pneumonia, Acinetobacter baumannii, Staphylococcus aureus, and Streptococcus pneumoniae) in clinical samples. Such a system would assist decision-making with respect to antibiotic use, help slow the onset of additional resistance, and improve disease surveillance. This array will provide pathogen detection, markers for presence and expression of antibiotic resistance genes/mutations and, where applicable and pertinent, strain-typing information that can also be used for diagnostic and in-hospital surveillance. The logical flow of the research plan will include capturing all current knowledge on antibiotic resistance characteristics for target pathogens; conducting additional analyses to further knowledge on species signatures and antibiotic resistance characteristics; developing novel PCR assays for these targets; validating developed assays, both individually and together on the high-density format array (using large strain and clinical sample repositories); developing the bioinformatic tools necessary to easily read and interpret array findings; and finally transferring developed technology to a clinical laboratory for evaluation. The project team has expertise from translational research, genomic analysis, clinical-based research, molecular epidemiology, public health and medical biotechnology development. Previously established collaborations among the team members will allow for immediate implementation of the proposed activities and early impacts on this grave threat. Clinical medicine and public health are facing the growing crisis of multi-drug resistance in common pathogens. More informative and rapid diagnostics are urgently needed to provide clinicians and public health officials the information necessary to appropriately respond to these infections. This project will develop, validate and translate a rapid high-density antibiotic-resistance detection system for five high-priority multi-drug resistant pathogens; such a system would assist decision-making with respect to antibiotic use, help slow the onset of additional resistance, and improve disease surveillance.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Evolution of a pathogen: a comparative genomics analysis identifies a genetic pathway to pathogenesis in Acinetobacter.
病原体的进化:比较基因组学分析确定了不动杆菌发病机制的遗传途径。
DOI:
10.1371/journal.pone.0054287
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[Sahl JW, Gillece JD, Schupp JM, Waddell VG, Driebe EM, Engelthaler DM, Keim P]
通讯作者:
Keim P
DOI:
10.1128/msphere.00464-17
发表时间:
2018-05
期刊:
mSphere
影响因子:
4.8
作者:
[Bowers JR, Driebe EM, Albrecht V, McDougal LK, Granade M, Roe CC, Lemmer D, Rasheed JK, Engelthaler DM, Keim P, Limbago BM]
通讯作者:
Limbago BM
DOI:
10.1371/journal.pone.0133727
发表时间:
2015
期刊:
PloS one
影响因子:
3.7
作者:
[Bowers JR, Kitchel B, Driebe EM, MacCannell DR, Roe C, Lemmer D, de Man T, Rasheed JK, Engelthaler DM, Keim P, Limbago BM]
通讯作者:
Limbago BM
DOI:
10.1128/mbio.00630-15
发表时间:
2015-07-21
期刊:
mBio
影响因子:
6.4
作者:
[Struve C, Roe CC, Stegger M, Stahlhut SG, Hansen DS, Engelthaler DM, Andersen PS, Driebe EM, Keim P, Krogfelt KA]
通讯作者:
Krogfelt KA
DOI:
10.1186/1471-2334-13-339
发表时间:
2013-07-23
期刊:
BMC infectious diseases
影响因子:
3.7
作者:
[Engelthaler DM, Kelley E, Driebe EM, Bowers J, Eberhard CF, Trujillo J, Decruyenaere F, Schupp JM, Mossong J, Keim P, Even J]
通讯作者:
Even J
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
-
批准号:10689662
-
项目类别:
-
资助金额:$154.27万
-
财政年份:2022
-
负责人:Paul Stephen Keim
-
依托单位:
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
-
批准号:10689664
-
项目类别:
-
资助金额:$25.84万
-
财政年份:2022
-
负责人:Paul Stephen Keim
-
依托单位:
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
-
批准号:10356626
-
项目类别:
-
资助金额:$26.49万
-
财政年份:2022
-
负责人:Paul Stephen Keim
-
依托单位:
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
-
批准号:10356625
-
项目类别:
-
资助金额:$151.91万
-
财政年份:2022
-
负责人:Paul Stephen Keim
-
依托单位:
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
-
批准号:10891793
-
项目类别:
-
资助金额:$139.02万
-
财政年份:2022
-
负责人:Paul Stephen Keim
-
依托单位:
Functional genomic analyses of emerging Cryptococcus subtypes in North America
-
批准号:8386240
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2012
-
负责人:Paul Stephen Keim
-
依托单位:
Functional genomic analyses of emerging Cryptococcus subtypes in North America
-
批准号:8505370
-
项目类别:
-
资助金额:$22.61万
-
财政年份:2012
-
负责人:Paul Stephen Keim
-
依托单位:
Genomic Correlates with Differential Virulence in Melioidosis Animal Models
-
批准号:8260261
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2011
-
负责人:Paul Stephen Keim
-
依托单位:
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
-
批准号:8281561
-
项目类别:
-
资助金额:$97.88万
-
财政年份:2010
-
负责人:Paul Stephen Keim
-
依托单位:
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
-
批准号:8477122
-
项目类别:
-
资助金额:$96.07万
-
财政年份:2010
-
负责人:Paul Stephen Keim
-
依托单位:
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
-
批准号:8088115
-
项目类别:
-
资助金额:$88.92万
-
财政年份:2010
-
负责人:Paul Stephen Keim
-
依托单位:
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
-
批准号:7989059
-
项目类别:
-
资助金额:$87.5万
-
财政年份:2010
-
负责人:Paul Stephen Keim
-
依托单位:
Genomic-based diagnostics for Coccidioides the causative agent of Valley fever
-
批准号:7361301
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2009
-
负责人:Paul Stephen Keim
-
依托单位:
Genomic-based diagnostics for Coccidioides the causative agent of Valley fever
-
批准号:7842688
-
项目类别:
-
资助金额:$20.75万
-
财政年份:2009
-
负责人:Paul Stephen Keim
-
依托单位:
Genomic Correlates with Differential Virulence in Melioidosis Animal Models
-
批准号:7675196
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2009
-
负责人:Paul Stephen Keim
-
依托单位:
Burkholderia: International Collaborative Development of Novel Diagnostics
-
批准号:7324521
-
项目类别:
-
资助金额:$89.77万
-
财政年份:2007
-
负责人:Paul Stephen Keim
-
依托单位:
Burkholderia: International Collaborative Development of Novel Diagnostics
-
批准号:7493613
-
项目类别:
-
资助金额:$88.93万
-
财政年份:2007
-
负责人:Paul Stephen Keim
-
依托单位:
Burkholderia: International Collaborative Development of Novel Diagnostics
-
批准号:7679070
-
项目类别:
-
资助金额:$91.27万
-
财政年份:2007
-
负责人:Paul Stephen Keim
-
依托单位:
Burkholderia: International Collaborative Development of Novel Diagnostics
-
批准号:8137146
-
项目类别:
-
资助金额:$88.65万
-
财政年份:2007
-
负责人:Paul Stephen Keim
-
依托单位:
Burkholderia: International Collaborative Development of Novel Diagnostics
-
批准号:7925772
-
项目类别:
-
资助金额:$92.74万
-
财政年份:2007
-
负责人:Paul Stephen Keim
-
依托单位:
海外基金